Yu-Waye Chu - 10 Dec 2021 Form 4 Insider Report for FATE THERAPEUTICS INC (FATE)

Role
Senior VP Clinical Development
Signature
/s/ Cindy Tahl, as Attorney-in-Fact
Issuer symbol
FATE
Transactions as of
10 Dec 2021
Net transactions value
-$263,548
Form type
4
Filing time
13 Dec 2021, 16:53:51 UTC
Previous filing
22 Nov 2021
Next filing
13 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FATE Common Stock Options Exercise $122,400 +7,500 +6% $16.32 133,258 10 Dec 2021 Direct F1
transaction FATE Common Stock Sale $103,424 -2,097 -1.6% $49.32* 131,161 10 Dec 2021 Direct F1, F2
transaction FATE Common Stock Sale $45,378 -900 -0.69% $50.42* 130,261 10 Dec 2021 Direct F1, F3
transaction FATE Common Stock Sale $53,379 -1,045 -0.8% $51.08* 129,216 10 Dec 2021 Direct F1, F4
transaction FATE Common Stock Sale $95,418 -1,822 -1.4% $52.37* 127,394 10 Dec 2021 Direct F1, F5
transaction FATE Common Stock Sale $55,323 -1,031 -0.81% $53.66* 126,363 10 Dec 2021 Direct F1, F6
transaction FATE Common Stock Sale $32,748 -600 -0.47% $54.58* 126,763 10 Dec 2021 Direct F1, F7
transaction FATE Common Stock Sale $278 -5 -0% $55.54* 125,758 10 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FATE Stock Option (Right to Buy) Options Exercise $0 -7,500 -6.7% $0.000000 105,000 10 Dec 2021 Common Stock 7,500 $16.32 Direct F1, F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 9, 2020.
F2 Represents the weighted average sale price of the shares sold ranging from $48.95 to $49.87 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price within the ranges set forth in footnotes 2 through 7.
F3 Represents the weighted average sale price of the shares sold ranging from $49.96 to $50.89 per share.
F4 Represents the weighted average sale price of the shares sold ranging from $50.96 to $51.22 per share.
F5 Represents the weighted average sale price of the shares sold ranging from $52.09 to $52.87 per share.
F6 Represents the weighted average sale price of the shares sold ranging from $53.10 to $54.02 per share.
F7 Represents the weighted average sale price of the shares sold ranging from $54.33 to $54.98 per share.
F8 The option shall vest as to 25% of the underlying shares on April 15, 2020 and thereafter on a monthly basis for 36 additional months, subject to the Reporting Person's continuous service to the Issuer as of each such vesting date